^
    over1year
    A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients (clinicaltrials.gov)
    P1, N=150, Recruiting, Qilu Pharmaceutical Co., Ltd.
    New P1 trial • Metastases
    |
    GPC3 (Glypican 3)
    |
    QLS31903